Bio Pharma Dive
AUGUST 27, 2024
The platform is similar in concept to a service launched this year by Eli Lilly, and aims to give consumers easier access to Pfizer’s migraine, COVID-19 and flu treatments.
Pharmaceutical Technology
AUGUST 27, 2024
Unlike its close neighbour Thailand, Singapore has not yet confirmed an mpox clade Ib case.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
AUGUST 27, 2024
The launch of a single-use vial form of the popular weight loss medicine could help Lilly improve supply and compete with telehealth companies offering compounded versions.
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 27, 2024
(Thirdman/Pexels) The proverbial “sugar high” that follows the ingestion of a sweet treat is a familiar example of the potentially positive effects of food on mood.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
AUGUST 27, 2024
New biotech Navigator is working on drugs for immune diseases. Meanwhile, UCB sold its neurology and allergy business in China, and J&J's Peter Fasolo will retire this year.
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 27, 2024
In the ever-evolving pharmaceutical landscape, modified release (MR) dosage forms have emerged as a groundbreaking innovation, providing solutions that significantly improve patient compliance by simplifying complex drug regimens.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
AUGUST 27, 2024
If all newly eligible patients received Novo's GLP-1 drug, Medicare Part D spending could increase by $34 billion to $145 billion each year, according to new research.
Pharmaceutical Technology
AUGUST 27, 2024
Eli Lilly and Novo Nordisk have announced that the supply of their GLP-1 weight loss drugs has improved with increased availability of Zepbound, Mounjaro, Wegovy, and Trulicity.
Pharma Times
AUGUST 27, 2024
The spread of multiple bacteria could be tracked simultaneously through sequencing method
Pharmaceutical Technology
AUGUST 27, 2024
Rybrevant has been granted a Type II approval extension to treat NSCLC with EGFR mutations following the failure of TKI therapy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Pharma
AUGUST 27, 2024
Eli Lilly has come up with a new way of supplying its popular weight-loss drug Zepbound that the company hopes could expand access while addressing other issues such as high prices and off-label co | Eli Lilly is offering its popular weight-loss drug Zepbound directly to consumers at a discount through its own online pharmacy. The company hopes the move could expand access while addressing other issues such as high prices and off-label cosmetic usage.
Pharmaceutical Technology
AUGUST 27, 2024
Declared a PHEIC by the WHO, an mpox outbreak in the DRC is posing a threat to human health.
pharmaphorum
AUGUST 27, 2024
Pfizer has become the latest big pharma group to launch a web-based platform that opens up a direct-to-consumer channel for medicines access.This morning, the company announced the launch in the US of PfizerForAll, a digital platform that it says provides access to same-day appointments with healthcare professionals – in-person or via a $35 telehealth visit – along with home delivery of medicines and diagnostics, vaccination appointments, and payment support.
Pharmaceutical Technology
AUGUST 27, 2024
OUD is a chronic neurological disorder described as the consequences associated with repeated, compulsive use of opioid drugs.
pharmaphorum
AUGUST 27, 2024
Roche's PiaSky is the first therapy for rare blood disorder PNH that can be given by monthly subcutaneous injection in the EU.
Pharmaceutical Technology
AUGUST 27, 2024
The US FDA has granted fast track designation for BeiGene’s BGB-16673 to treat lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL).
pharmaphorum
AUGUST 27, 2024
US biotech MBX Biosciences, files for an IPO, seeking around $100 million to take a hypoparathyroidism candidate into phase 3
Pharmaceutical Technology
AUGUST 27, 2024
The EC has granted approval to Roche’s PiaSky for the treatment of paroxysmal nocturnal haemoglobinuria in adult and adolescent patients.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
AUGUST 27, 2024
J&J's Balversa has been approved in the EU for advanced bladder cancer with FGFR3 genetic alterations after one line of prior therapy
Pharmaceutical Technology
AUGUST 27, 2024
UCB has entered a divestment agreement in China to sell its mature neurology and allergy business to CBC Group and Mubadala for $680m.
Fierce Pharma
AUGUST 27, 2024
For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of federal agencies. | In June, when the Supreme Court voted 6-3 to overturn the Chevron doctrine, it brought significant impact for the healthcare industry and federal regulators like the FDA and the Centers for Medicare & Medicaid Services.
Pharmaceutical Technology
AUGUST 27, 2024
SIFI has received the European Commission approval for AKANTIOR to treat acanthamoeba keratitis (AK), a rare and severe corneal infection.
pharmaphorum
AUGUST 27, 2024
Regeneron's Ordspono (odronextamab) for non-Hodgin lymphoma (NHL) is cleared in EU five months after being turned down by the FDA
Pharmaceutical Commerce
AUGUST 27, 2024
The agency provides an update surrounding the Act’s implementation efforts.
BioPharma Reporter
AUGUST 27, 2024
Microbiotica has received the green light from EU and UK regulatory authorities to start phase 1b studies for its microbiome medicines in advanced melanoma and ulcerative colitis.
Pharmaceutical Commerce
AUGUST 27, 2024
The latest news for pharma industry insiders.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Rethinking Clinical Trials
AUGUST 27, 2024
The Pain Management Collaboratory (PMC) will sponsor a series of presentations as part of the VA Spotlight on Pain Management (SoPM) Cyberseminar series, highlighting the accomplishments and future initiatives of the PMC. These webinars will feature early findings, lessons learned, and future directions for research based on the activities of PMC Pragmatic Clinical Trials.
pharmaphorum
AUGUST 27, 2024
Considering adopting AI platforms for drug discovery? This structured framework will help you evaluate and choose the right platform for your needs.
Outsourcing Pharma
AUGUST 27, 2024
In the ongoing battle against Alzheimerâs disease, early diagnosis is crucial.
pharmaphorum
AUGUST 27, 2024
Learn how to effectively deal with fragmented data by leveraging Veeva Open Data in this informative white paper. Gain insights on how to streamline data management processes and improve data quality.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
285 
Let's personalize your content